Osteocyte mechanosensing following short-term and long-term treatment with sclerostin antibody

We are thrilled to announce that Prescient has been awarded a silver medal by EcoVadis. This achievement places us in the top 25 percent of companies assessed by EcoVadis, a leading sustainability rating platform.

Prescient Healthcare Group supported Incyte Biosciences Iberia in executing ImPATH (IMprove PATient PATHway in DLBCL), a project that engaged a multidisciplinary team of experts to assess the patient care pathway for DLBCL in Spain.

Here at Prescient, we’re excited to share a major step in our sustainability journey. After careful calculation of our 2022 greenhouse gas emissions from business travel and commuting, we partnered with ACT Commodities Group, a leading provider of market-based environmental solutions. With its support, we have successfully arranged to offset our carbon emissions by investing in a wind power project that will generate 44 MW of electricity from previously barren land in Maharashtra, India.